Tales from the Heart

Lisa Salberg and Dr. Alex de Feria explore the latest developments in HCM care, from promising non-obstructive HCM therapies to the challenges of recognizing symptoms, managing medications, and assessing sudden cardiac death risk. They also discuss clinical trials, fibrosis research, and why the future of HCM treatment has never looked brighter.

 

This conversation was recorded May 28, 2026.

Host Lisa Salberg talks with Dr. Ronald H. Wharton about building a nationally recognized HCM Center of Excellence at Northwell Health on Long Island. They discuss patient education, new myosin inhibitor therapies, clinical trials, and why specialized HCM care can change lives for patients and families.

 

This conversation was recorded 5/21/26

Lisa Salberg welcomes Steven Kelley and Matt Grant to discuss HCMA’s new discussion group for men 40-ish and under living with HCM. The conversation explores friendship, mental health, dating, devices, and building a supportive space where younger men can openly share their experiences and connect with others facing similar challenges.

 

This conversation was recorded May 15, 2026.

Lisa Salberg and Dr. Michael Ayers explore the rapidly evolving world of HCM treatment, from myosin inhibitors and clinical trials to AFib management and patient-centered care. The episode also dives into advocacy, drug safety concerns, and why personalized treatment strategies matter more than ever for people living with hypertrophic cardiomyopathy.

This conversation was recorded May 15, 2026.

Lisa Salberg and Dr. Marty Maron break down the rapidly changing landscape of HCM treatment, including the growing role of myosin inhibitors and what new clinical trial data could mean for patients. The conversation also explores beta blockers, shared care models, Centers of Excellence, and why personalized treatment matters more than ever.

 

This conversation was recorded May 8, 2026.

Lisa Salberg welcomes Ram Khandelwal and Pallari Kamat for a global conversation about expanding HCM awareness and patient advocacy across India. The episode explores the challenges of diagnosis, healthcare access, and education while highlighting efforts to build stronger support systems for patients and families worldwide.

 

This conversation was recorded May 7, 2026.

Lisa Salberg and Dr. Marty Maron break down major new clinical trial results that could change treatment for patients with non obstructive HCM. They explain what the Acacia HCM trial found, why experts call it a transformative moment, and what the next steps could mean for patients around the world.

 

This conversation was recorded May 5, 2026.

Lisa Salberg and Dr. Matt Martinez break down how medical management for HCM is rapidly evolving, from traditional beta blockers to game-changing myosin inhibitors. They also preview what’s next, including emerging drugs, clinical trials, and new approaches that could reshape care in the near future.

 

This conversation was recorded May 1, 2026

Lisa Salberg and Dr. Ethan Rowin break down new data on atrial fibrillation risk in patients taking myosin inhibitors for HCM. They explain what the latest research shows, how risk compares to traditional care, and what patients should watch for as treatment options continue to evolve.

 

This conversation was recorded April 28, 2026.

Lisa Salberg is joined by Lynda Neuhausen and Vi Tang to launch a new discussion group focused on the genetics of hypertrophic cardiomyopathy. They explore the science behind genetic testing, the emotional impact on families, and how open conversation can help patients navigate uncertainty and risk together.

 

This conversation was recorded April 24, 2026.